Trial NCT00006003

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02346
Secondary IDs: 10395 CDR0000068011 N01CM17102

Last trial update was posted on 2013-01-24

MeSH Interventions

Semaxinib

MeSH Conditions

Melanoma

Other Conditions

Recurrent Melanoma Stage IV Melanoma

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID